| |
| |
|
| Insider
Information: |
Jones Cecilia |
| Relationship: |
Chief Financial Officer |
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
18,604 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$513,167 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
18,604 |
|
|
| Total
Value |
$513,167 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Logicbio Therapeutics, Inc. |
LOGC |
Chief Financial Officer |
2022-01-12 |
3,764 |
2022-01-11 |
0 |
Premium* |
|
|
Agios Pharmaceuticals Inc |
AGIO |
Chief Financial Officer |
2024-03-05 |
14,840 |
2023-06-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGIO |
Agios Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2024-03-05 |
4 |
AS |
$32.57 |
$21,887 |
D/D |
(672) |
14,840 |
0 |
% |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2024-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,000 |
15,512 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2024-01-24 |
4 |
AS |
$21.64 |
$40,813 |
D/D |
(1,886) |
13,069 |
0 |
% |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2024-01-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,380 |
14,955 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2023-06-30 |
4 |
S |
$28.36 |
$45,291 |
D/D |
(1,597) |
3,783 |
0 |
% |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2023-06-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,380 |
5,380 |
0 |
- |
|
| LOGC |
Logicbio Therapeutics, In... |
Chief Financial Officer |
• – – |
2022-01-12 |
4 |
D |
$2.01 |
$4,372 |
D/D |
(2,175) |
3,764 |
0 |
- |
|
| LOGC |
Logicbio Therapeutics, In... |
Chief Financial Officer |
• – – |
2022-01-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,939 |
5,939 |
0 |
- |
|
8 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
